Risk factors and mortality of the newly emerging Candida auris in a university hospital in Saudi Arabia.

IF 4.6 2区 生物学 Q1 MYCOLOGY
Reham Kaki
{"title":"Risk factors and mortality of the newly emerging <i>Candida auris</i> in a university hospital in Saudi Arabia.","authors":"Reham Kaki","doi":"10.1080/21501203.2023.2227218","DOIUrl":null,"url":null,"abstract":"<p><p><i>Candida auris</i> presents a global health threat. We investigated risk factors and mortality of <i>Candida auris</i> infections in a retrospective study in Saudi Arabia. We included 27 patients ≥14  with invasive <i>Candida auris</i> from 2015-2022, with median age 58, and 66.7% males. All patients had indwelling devices. The most common infection sources were central line-associated bloodstream infection in 17 (63.0%), and urinary tract infections in four (12%). Fever and shock were observed in nine patients (33.3%) each, and 22 (81%) were admitted to the intensive care unit. Common comorbidities were diabetes and heart disease in 13 (48.1%) patients each. The median hospital stay was 78 days, and the median Charlson index was 4. The <i>C. auris</i> cultures were 100% susceptible to voriconazole, caspofungin, and amphotericin, while three were fully susceptible to fluconazole (11.1%). Despite treatment, 18 (66.7%) patients died. In conclusion, invasive <i>C. auris</i> infection had varied presentations. All patients had indwelling devices, and many had lengthy hospital stays. All isolates were susceptible to amphotericin and echinocandins, while few were fully susceptible to fluconazole.</p>","PeriodicalId":18833,"journal":{"name":"Mycology","volume":"14 3","pages":"256-263"},"PeriodicalIF":4.6000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f6/41/TMYC_14_2227218.PMC10424598.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mycology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/21501203.2023.2227218","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MYCOLOGY","Score":null,"Total":0}
引用次数: 1

Abstract

Candida auris presents a global health threat. We investigated risk factors and mortality of Candida auris infections in a retrospective study in Saudi Arabia. We included 27 patients ≥14  with invasive Candida auris from 2015-2022, with median age 58, and 66.7% males. All patients had indwelling devices. The most common infection sources were central line-associated bloodstream infection in 17 (63.0%), and urinary tract infections in four (12%). Fever and shock were observed in nine patients (33.3%) each, and 22 (81%) were admitted to the intensive care unit. Common comorbidities were diabetes and heart disease in 13 (48.1%) patients each. The median hospital stay was 78 days, and the median Charlson index was 4. The C. auris cultures were 100% susceptible to voriconazole, caspofungin, and amphotericin, while three were fully susceptible to fluconazole (11.1%). Despite treatment, 18 (66.7%) patients died. In conclusion, invasive C. auris infection had varied presentations. All patients had indwelling devices, and many had lengthy hospital stays. All isolates were susceptible to amphotericin and echinocandins, while few were fully susceptible to fluconazole.

沙特阿拉伯一所大学医院新发耳念珠菌的危险因素和死亡率
耳念珠菌对全球健康构成威胁。我们在沙特阿拉伯的一项回顾性研究中调查了耳念珠菌感染的危险因素和死亡率。我们纳入了2015-2022年27例≥14例侵袭性耳念珠菌患者,中位年龄58岁,男性占66.7%。所有患者均有留置装置。最常见的感染源为17例(63.0%)中央静脉相关血流感染,4例(12%)尿路感染。发热和休克各9例(33.3%),其中22例(81%)入住重症监护病房。常见的合并症是糖尿病和心脏病,各13例(48.1%)。住院时间中位数为78天,Charlson指数中位数为4。金黄色葡萄球菌培养物对伏立康唑、卡泊芬净和两性霉素的敏感性为100%,对氟康唑的敏感性为11.1%。尽管治疗,18例(66.7%)患者死亡。总之,侵袭性耳球菌感染具有多种表现。所有患者都有留置装置,许多人住院时间很长。所有分离株均对两性霉素和棘白菌素敏感,少数对氟康唑完全敏感。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Mycology
Mycology Medicine-Infectious Diseases
CiteScore
9.10
自引率
0.00%
发文量
18
审稿时长
13 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信